Immune system cells and a drug used for treating rheumatoid arthritis will be studied in an effort to reduce inflammation in kidney transplants and improve long-term function.
If successful, the PRESERVE-1 trial could be a significant clinical breakthrough in the treatment of the condition by prolonging pregnancy and improving outcomes.
Becker’s Hospital Review has named the UAB Comprehensive Cancer Center as one of the “100 Hospitals and Health Systems With Great Oncology Programs.”
The UAB Callahan Eye Hospital will open its remodeled emergency department and newly renovated Lions Eye Clinic at a ceremony on Thursday, July 31.
Casey Weaver, M.D., the Wyatt and Susan Haskell Professor of Medical Excellence in the Department of Pathology, has been elected a Fellow of the American Academy of Microbiology.
Kenneth Hoyt received an NIH award to support the development of a non-invasive ultrasound imaging technique for monitoring drug treatment in cancer patients.
U.S. News & World Report on July 15 released its 2014-2015 Best Hospitals list, and UAB Hospital continues to rank No. 1 in both Alabama and Birmingham.
Boni Elewski, M.D., led one of two trials featured in the New England Journal of Medicine that show secukinumab is a safe and effective psoriasis treatment.
David B. Allison, associate dean for Science in the UAB School of Public Health, has been named a fellow of The Gerontological Society of America.
Since December, 21 living donor kidney transplants that have taken place at UAB are connected as donors “pay it forward” for a recipient to keep the chain going, and more transplants are scheduled for July.